David Nicholas Gee

CIK: 0001547134

Transaction Breakdown

Open Market Buys (P)0 (0.0%)

High conviction signal

Open Market Sales (S)6 (100.0%)

Position reduction

Option Exercises (M)0 (0.0%)

Derivative conversions

Awards (A)0 (0.0%)

Compensation grants

Other (G, F, J, C, D, …)0 (0.0%)

Gifts, tax withholding, conversions, dispositions to the issuer and other codes

Companies & Roles (1)

CLBT

Cellebrite DI Ltd.

Officer

Discretionary Trading P&L

Holdings

Transaction History (6 total)

CLBT
Cellebrite DI Ltd.
Aug 24, 2026
Sale(S)
Direct
4.3K shares at avg. $11.36$49K
CLBT
Cellebrite DI Ltd.
Aug 21, 2026
Sale(S)
Direct
2.2K shares at avg. $11.24$25K
CLBT
Cellebrite DI Ltd.
Aug 12, 2026
Sale(S)
Direct
230 shares at avg. $16.07$4K
CLBT
Cellebrite DI Ltd.
May 21, 2026
Sale(S)
Direct
2.2K shares at avg. $13.10$29K
CLBT
Cellebrite DI Ltd.
May 21, 2026
Sale(S)
Direct
3.4K shares at avg. $13.15$45K
CLBT
Cellebrite DI Ltd.
May 12, 2026
Sale(S)
Direct
228 shares at avg. $13.01$3K

		Type	Shares	Price		Ownership
Aug 24, 2026	CLBT Cellebrite DI Ltd.	Sale(S)	4,323	$11.36	$49,111	Direct
Aug 21, 2026	CLBT Cellebrite DI Ltd.	Sale(S)	2,198	$11.24	$24,709	Direct
Aug 12, 2026	CLBT Cellebrite DI Ltd.	Sale(S)	230	$16.07	$3,696	Direct
May 21, 2026	CLBT Cellebrite DI Ltd.	Sale(S)	2,243	$13.10	$29,383	Direct
May 21, 2026	CLBT Cellebrite DI Ltd.	Sale(S)	3,430	$13.15	$45,094	Direct
May 12, 2026	CLBT Cellebrite DI Ltd.	Sale(S)	228	$13.01	$2,966	Direct

1-6 of 6 transactions

About GEE DAVID NICHOLAS

GEE DAVID NICHOLAS (SEC CIK 0001547134) files insider reports with the SEC as Chief Marketing Officer of Cellebrite DI Ltd. (CLBT).

Signal8 holds 6 ownership filings by GEE DAVID NICHOLAS (1 Form 3, 5 Form 4), filed between Mar 18, 2026 and Aug 25, 2026. Those filings report 6 transactions, from May 12, 2026 to Aug 24, 2026. Signal8's Form 4 history starts in Sep 2024.

The business address on GEE DAVID NICHOLAS's filings is in PETAH TIKVA.

Recent filings by GEE DAVID NICHOLAS

Aug 24, 2026: Open-market sale of CLBT shares (Form 4, code S).
Aug 21, 2026: Open-market sale of CLBT shares (Form 4, code S).
Aug 12, 2026: Open-market sale of CLBT shares (Form 4, code S).
May 21, 2026: Open-market sales of CLBT shares (2 lines, Form 4, code S).
May 12, 2026: Open-market sale of CLBT shares (Form 4, code S).

Other insiders filing for Cellebrite DI Ltd. (CLBT)

Barter David, Chief Financial Officer
Utsumi Ryusuke, Director
Domnitz Yonatan, Director
CLAMMER ADAM, Director
Ramji Shiven, Chief Executive Officer
Van Buren Brandon, Director

How to read Form 4 transaction codes